Orally Administered Corticosteroid Compositions

Patent No. EP3403654 (titled "Orally Administered Corticosteroid Compositions") was filed by Adare I on Sep 30, 2010. The application was issued on Jul 31, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR FALK PHARMAApr 28, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3403654

ADARE I
Application Number
EP18178891A
Filing Date
Sep 30, 2010
Status
Granted And Under Opposition
Jun 28, 2019
Publication Date
Jul 31, 2019